FindTrial
Sign In

Study for meropenem in the treatment of CAP\HAP\VAP and clinical decision support of based on AI deep learning algorithm

Study for meropenem in the treatment of CAP\HAP\VAP and clinical decision support of based on AI deep learning algorithm

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029190
Enrollment
Unknown
Registered
2020-01-17
Start date
2020-01-18
Completion date
Unknown
Last updated
2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meropenem for CAP\HAP\VAP

Interventions

Case series:meropenem

Sponsors

The Second Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: All patients who used meropenem during hospitalization

Exclusion criteria

Exclusion criteria: All patients who used meropenem in combination during hospitalization.And in the research of big data,in the data cleaning stage,data is cleaned for missing values,outliers,and extreme data is excluded for modeling calculation.

Design outcomes

Primary

MeasureTime frame
C-reactive protein(CRP);Procalcitonin(PCT);white blood cell(WBC);Neutrophil alkaline phosphatase;liver function;renal function;—

Countries

China

Contacts

Public ContactWU KE

Central Hospital of Pu-Lan-Dian

drenched92@163.com+86 15104051199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026